Friday, August 7 | 3:15 to 6:15 pm ET
Join us for a free public workshop to inform a fast-track study that will help policymakers plan for equitable allocation of a limited initial supply of vaccine against COVID-19.
Topics will include (subject to change):
- Updates on current vaccine development and distribution activities, including Operation Warp Speed and the World Health Organization’s vaccine allocation framework
- Learning from past vaccine allocation experiences in the United States and strategies to ensure public trust and equity
- The role of infectious disease dynamics in informing vaccine allocation strategy
Study Background: A Framework for Equitable Allocation of Vaccine for the Novel Coronavirus
In response to a request from the NIH and CDC, the NAM and the National Academies have formed an expert committee to develop an overarching framework for equitable allocation of vaccines against COVID-19.
The committee will consider what criteria should be used to set priorities for equitable distribution among groups of potential vaccine recipients, taking into account factors such as population health disparities; individuals at higher risk because of health status, occupation, or living conditions; and geographic distribution of active virus spread. In addition, the committee will consider how communities of color can be assured access to COVID-19 vaccines in the U.S. and recommend strategies to mitigate vaccine hesitancy among the American public.
For more information, visit the study webpage.
To receive updates on this activity, join our COVID-19 & Infectious Diseases listserv.
For questions, contact COVIDVaccineFramework@nas.edu.
For media inquiries, contact Dana Korsen at email@example.com.